RADNOR, PA / ACCESSWIRE / May 10, 2018 / Kaskela Law LLC reminds Myriad Genetics, Inc. (NASDAQ: MYGN) ("Myriad" or the "Company") shareholders ... Following this disclosure, shares of the Company's stock fell $4.01 per …
Massaro was surprised to discover from his survey that more doctors responded they are aware of Genomic Health's tests over Myriad Genetics, Inc. (NASDAQ: MYGN). The analyst noted ... profile on Genomic Health's stock has "swung to …
Looking for a stock that might be in a good position to beat earnings at its next report? Consider Myriad Genetics Inc. (MYGN), a firm in the Drugs industry, which could be a great candidate for another beat. This company has seen a nice …
Myriad Genetics Inc. (MYGN) reported first quarter EPS of $0.23 after the close ... before settling into a range. The stock closed down by 3.09 at $16.40 on above average volume. Myriad Genetics dropped below a 3-week trading range and …
May 06, 2018 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Myriad Genetics, Inc. (NASDAQ:MYGN) (“Myriad” or ... shares of the Company’s stock fell $4.01 per share, or …
The stock has gained 21.32% over the last year. 7. Maxim Integrated Products Inc. (MXIM): Semiconductor Line Industry. Market cap of $6.44B. Current price at $21.86. MYGN recently set aside $200 million for share buybacks. Might be …
Investors found another reason to bid up shares of Myriad Genetics Inc. /quotes/zigman/58124 /quotes/nls/mygn MYGN, which is sole owner of ... hitting a fresh 52-week high. The stock surged last week on third-quarter results that …
Mayne said Tikosyn U.S. sales last year were $150 million. Myriad Genetics, Inc. (NASDAQ: MYGN) jumped nearly 5 percent after the company boosted its stock buyback plan by $200 million. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) …